PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling.
Abstract |
|
Authors | Thomas T Su, Beichu Guo, Yuko Kawakami, Karen Sommer, Keun Chae, Lisa A Humphries, Roberta M Kato, Shin Kang, Lisa Patrone, Randolph Wall, Michael Teitell, Michael Leitges, Toshiaki Kawakami, David J Rawlings |
Journal | Nature immunology
(Nat Immunol)
Vol. 3
Issue 8
Pg. 780-6
(Aug 2002)
ISSN: 1529-2908 [Print] United States |
PMID | 12118249
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate
- Enzyme Inhibitors
- I-kappa B Proteins
- Indoles
- Isoenzymes
- Maleimides
- Mesylates
- NF-kappa B
- Pyrroles
- Receptors, Antigen, B-Cell
- Ro 31-8425
- Protein Serine-Threonine Kinases
- Chuk protein, mouse
- I-kappa B Kinase
- Ikbkb protein, mouse
- Ikbke protein, mouse
- Protein Kinase C
- Protein Kinase C beta
|
Topics |
- Animals
- Apoptosis
(immunology)
- B-Lymphocytes
(enzymology, immunology)
- Enzyme Inhibitors
(pharmacology)
- Flow Cytometry
- I-kappa B Kinase
- I-kappa B Proteins
(immunology)
- Immunoblotting
- Indoles
(pharmacology)
- Isoenzymes
(antagonists & inhibitors, immunology)
- Lymphoma, B-Cell
(immunology)
- Maleimides
(pharmacology)
- Mesylates
(pharmacology)
- Mice
- Mice, Inbred BALB C
- Mice, Knockout
- NF-kappa B
(immunology)
- Protein Kinase C
(antagonists & inhibitors, immunology)
- Protein Kinase C beta
- Protein Serine-Threonine Kinases
(immunology, metabolism)
- Pyrroles
(pharmacology)
- Receptors, Antigen, B-Cell
(immunology)
- Signal Transduction
(immunology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|